IGF-1 LR3 (IGF1-LR3)

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a synthetic analog of endogenous IGF-1, modified with an arginine substitution at position 3 and an extended peptide sequence to enhance receptor interaction duration in laboratory research models. In controlled experimental environments, IGF-1 LR3 has been studied for its binding affinity to the IGF-1 receptor (IGF1R) and its involvement in cellular growth, proliferation, and signaling pathway research. Preclinical investigations have examined IGF-1 LR3 for its interaction with PI3K/Akt and MAPK signaling cascades associated with cellular differentiation and metabolic regulation frameworks. Ongoing scientific studies continue to evaluate its molecular stability, receptor-binding characteristics, and downstream intracellular signaling mechanisms within experimental endocrine and cellular biology research settings. This research peptide is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. IGF-1 LR3 is intended strictly for laboratory research and analytical purposes only and is not for human consumption.